{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:40Z","timestamp":1772120020792,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12149-025-02094-9","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T06:52:15Z","timestamp":1755672735000},"page":"1306-1318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of repeated trans-arterial radioembolization with multi-compartment dosimetry"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6199-8551","authenticated-orcid":false,"given":"Cigdem","family":"Soydal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burak","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Araz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irem","family":"Mesci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre Can","family":"\u00c7elebio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriye Ozlem","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"2094_CR1","unstructured":"Wasan HS, Gibbs P, Sharma N, Taieb J, Heinemann V, Ricke J, et al. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials. Lancet Oncol [Internet]. 2017 [cited 2023 Sep 25];18:1159\u201371. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28781171\/"},{"key":"2094_CR2","doi-asserted-by":"crossref","unstructured":"Ricke J, Kl\u00fcmpen HJ, Amthauer H, Bargellini I, Bartenstein P, de Toni EN, et al. Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma. J Hepatol [Internet]. 2019 [cited 2023 Sep 25];71:1164\u201374. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31421157\/","DOI":"10.1016\/j.jhep.2019.08.006"},{"key":"2094_CR3","doi-asserted-by":"crossref","unstructured":"Klompenhouwer EG, Dresen RC, Verslype C, Laenen A, De Hertogh G, Deroose CM, et al. Safety and efficacy of transarterial radioembolisation in patients with intermediate or advanced stage hepatocellular carcinoma refractory to chemoembolisation. Cardiovasc Intervent Radiol [Internet]. 2017 [cited 2025 Mar 9];40:1882\u201390. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28685382\/","DOI":"10.1007\/s00270-017-1739-5"},{"key":"2094_CR4","doi-asserted-by":"crossref","unstructured":"Salem R, Gabr A, Riaz A, Mora R, Ali R, Abecassis M, et al. Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience. Hepatology [Internet]. 2018 [cited 2025 Mar 9];68:1429\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29194711\/","DOI":"10.1002\/hep.29691"},{"key":"2094_CR5","doi-asserted-by":"crossref","unstructured":"Gao R, Gabr A, Mouli S, Riaz A, Kulik L, Lewandowski RJ, et al. Toxicity and survival of hepatocellular carcinoma patients with hepatitis b infection treated with yttrium-90 radioembolization: an updated 15-year study. J Vasc Interv Radiol [Internet]. 2020 [cited 2025 Mar 9];31:401\u2013408.e1. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31983593\/","DOI":"10.1016\/j.jvir.2019.08.033"},{"key":"2094_CR6","doi-asserted-by":"crossref","unstructured":"Benson AB, Geschwind JF, Mulcahy MF, Rilling W, Siskin G, Wiseman G, et al. Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study. Eur J Cancer [Internet]. 2013 [cited 2025 Mar 9];49:3122\u201330. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23777743\/","DOI":"10.1016\/j.ejca.2013.05.012"},{"key":"2094_CR7","doi-asserted-by":"crossref","unstructured":"Masthoff M, Schindler P, Harders F, Heindel W, Wilms C, Schmidt HH, et al. Repeated radioembolization in advanced liver cancer. Ann Transl Med [Internet]. 2020 [cited 2025 Mar 9];8:1055. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7575953\/","DOI":"10.21037\/atm-20-2658"},{"key":"2094_CR8","doi-asserted-by":"crossref","unstructured":"Reed DK, Stewart WH, Banta T, Lirette ST, Campbell GS, Patel A. Repeated transarterial radioembolization adverse event and hepatotoxicity profile in cirrhotic patients with hepatocellular carcinoma: a single-center experience. Cureus [Internet]. 2022 [cited 2025 Mar 9];14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35494977\/","DOI":"10.7759\/cureus.23578"},{"key":"2094_CR9","doi-asserted-by":"crossref","unstructured":"Filippi L, Di Costanzo GG, Tortora R, Pelle G, Cianni R, Schillaci O, et al. Repeated treatment with 90y-microspheres in intrahepatic cholangiocarcinoma relapsed after the first radioembolization. Cancer Biother Radiopharm [Internet]. 2019 [cited 2025 Mar 9];34:231\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30758985\/","DOI":"10.1089\/cbr.2018.2718"},{"key":"2094_CR10","doi-asserted-by":"crossref","unstructured":"Lam MGEH, Louie JD, Iagaru AH, Goris ML, Sze DY. Safety of repeated yttrium-90 radioembolization. Cardiovasc Intervent Radiol [Internet]. 2013 [cited 2025 Mar 9];36:1320\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23354961\/","DOI":"10.1007\/s00270-013-0547-9"},{"key":"2094_CR11","doi-asserted-by":"crossref","unstructured":"Chiesa C, Sjogreen-Gleisner K, Walrand S, Strigari L, Flux G, Gear J, et al. EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres. EJNMMI Phys [Internet]. 2021 [cited 2023 Sep 28];8:1\u201344. Available from: https:\/\/ejnmmiphys.springeropen.com\/articles\/10.1186\/s40658-021-00394-3","DOI":"10.1186\/s40658-021-00394-3"},{"key":"2094_CR12","unstructured":"Simplicit90y Dosimetry Planning Software | Read more [Internet]. [cited 2024 Jul 1]. Available from: https:\/\/www.mirada-medical.com\/interventional-radiology"},{"key":"2094_CR13","doi-asserted-by":"crossref","unstructured":"Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging [Internet]. 2022 [cited 2024 Jul 29];49:1682\u201399. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35146577\/","DOI":"10.1007\/s00259-021-05600-z"},{"key":"2094_CR14","doi-asserted-by":"crossref","unstructured":"Maxwell AWP, Mendoza HG, Sellitti MJ, Camacho JC, Deipolyi AR, Ziv E, et al. Optimizing 90Y particle density improves outcomes after radioembolization. Cardiovasc Intervent Radiol [Internet]. 2022 [cited 2025 Feb 15];45:958\u201369. Available from: https:\/\/link.springer.com\/article\/10.1007\/s00270-022-03139-6","DOI":"10.1007\/s00270-022-03139-6"},{"key":"2094_CR15","unstructured":"3D Slicer image computing platform | 3D Slicer [Internet]. [cited 2024 Jul 29]. Available from: https:\/\/www.slicer.org\/"},{"key":"2094_CR16","doi-asserted-by":"crossref","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging [Internet]. 2012 [cited 2024 Mar 25];30:1323\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22770690\/","DOI":"10.1016\/j.mri.2012.05.001"},{"key":"2094_CR17","unstructured":"Demir B. 4burakfe\/SlicerRadioembolizationDosimetry: Taranis \u2013 Radiembolization Dosimetry. A simple module that allows users to perform voxel-based dosimetry with patient-relative and absolute calibration methods for treatments of liver tumors with Y-90 microspheres. [Internet]. [cited 2025 Jul 25]. Available from: https:\/\/github.com\/4burakfe\/SlicerRadioembolizationDosimetry"},{"key":"2094_CR18","doi-asserted-by":"crossref","unstructured":"Pinter C, Lasso A, Wang A, Jaffray D, Fichtinger G. SlicerRT: Radiation therapy research toolkit for 3D Slicer. Med Phys [Internet]. 2012 [cited 2024 Dec 18];39:6332\u20138. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1118\/1.4754659","DOI":"10.1118\/1.4754659"},{"key":"2094_CR19","unstructured":"SlicerRT [Internet]. [cited 2024 Dec 18]. Available from: https:\/\/slicerrt.github.io\/"},{"key":"2094_CR20","doi-asserted-by":"crossref","unstructured":"Zarva A, Mohnike K, Damm R, Ruf J, Seidensticker R, Ulrich G, et al. Safety of repeated radioembolizations in patients with advanced primary and secondary liver tumors and progressive disease after first selective internal radiotherapy. J Nucl Med [Internet]. 2014 [cited 2025 Mar 9];55:360\u20136. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24516256\/","DOI":"10.2967\/jnumed.113.127662"},{"key":"2094_CR21","doi-asserted-by":"crossref","unstructured":"Elsayed M, Ermentrout RM, Sethi I, Bercu ZL, Galt JR, Whitmore M, et al. Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization: Outcomes at a Large Tertiary Care Center. Clin Nucl Med [Internet]. 2020 [cited 2025 Mar 9];45:100\u20134. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31876805\/","DOI":"10.1097\/RLU.0000000000002828"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02094-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02094-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02094-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:25:34Z","timestamp":1762763134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02094-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2094"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02094-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6764926\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Ankara University (No. \u013001-100-25).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study was approved by the Ethics Committee of Ankara University, and informed consent was obtained from all patients prior to treatment and all other procedures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}